Systemic autoimmune myopathies: a prospective phase 4 controlled trial of an inactivated virus vaccine against SARS-CoV-2
出版年份 2021 全文链接
标题
Systemic autoimmune myopathies: a prospective phase 4 controlled trial of an inactivated virus vaccine against SARS-CoV-2
作者
关键词
-
出版物
RHEUMATOLOGY
Volume -, Issue -, Pages -
出版商
Oxford University Press (OUP)
发表日期
2021-10-14
DOI
10.1093/rheumatology/keab773
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Sex Differences in Immunity: Implications for the Development of Novel Vaccines Against Emerging Pathogens
- (2021) Anahita Fathi et al. Frontiers in Immunology
- Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study
- (2021) Hannah Bower et al. ANNALS OF THE RHEUMATIC DISEASES
- Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry
- (2021) Anja Strangfeld et al. ANNALS OF THE RHEUMATIC DISEASES
- A New SARS CoV-2 Dual Purpose Serology Test: Highly Accurate Infection Tracing and Neutralizing Antibody Response Detection
- (2021) Sean C. Taylor et al. JOURNAL OF CLINICAL MICROBIOLOGY
- COVID-19 vaccination and antirheumatic therapy
- (2021) Jack Arnold et al. RHEUMATOLOGY
- Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases
- (2021) Brian J Boyarsky et al. ANNALS OF THE RHEUMATIC DISEASES
- SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases
- (2021) David Simon et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab, but not other antirheumatic therapies, is associated with impaired serological response to SARS- CoV-2 vaccination in patients with rheumatic diseases
- (2021) Robert Spiera et al. ANNALS OF THE RHEUMATIC DISEASES
- Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort
- (2021) Ulf M Geisen et al. ANNALS OF THE RHEUMATIC DISEASES
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- A systematic review and meta-analysis of geographic differences in comorbidities and associated severity and mortality among individuals with COVID-19
- (2021) Bhaskar Thakur et al. Scientific Reports
- American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients with Rheumatic and Musculoskeletal Diseases – Version 1
- (2021) Jeffrey R Curtis et al. Arthritis & Rheumatology
- Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study
- (2021) Victoria Furer et al. ANNALS OF THE RHEUMATIC DISEASES
- Disease activity and humoral response in patients with inflammatory rheumatic diseases after two doses of the Pfizer mRNA vaccine against SARS-CoV-2
- (2021) Yolanda Braun-Moscovici et al. ANNALS OF THE RHEUMATIC DISEASES
- A recommended paradigm for vaccination of rheumatic disease patients with the SARS-CoV-2 vaccine
- (2021) Haralampos M. Moutsopoulos JOURNAL OF AUTOIMMUNITY
- Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial
- (2021) Ana C. Medeiros-Ribeiro et al. NATURE MEDICINE
- Safety of the ChAdOx1 nCoV-19 and the BBV152 vaccines in 724 patients with rheumatic diseases: a post-vaccination cross-sectional survey
- (2021) Somy Cherian et al. RHEUMATOLOGY INTERNATIONAL
- Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
- (2020) Victor M Corman et al. Eurosurveillance
- A prospective cross-sectional study of serum IL-17A in antisynthetase syndrome
- (2020) Gustavo Luiz Behrens Pinto et al. CLINICAL RHEUMATOLOGY
- Prevalence of co‐morbidities and their association with mortality in patients with COVID ‐19: A systematic review and meta‐analysis
- (2020) Awadhesh K. Singh et al. DIABETES OBESITY & METABOLISM
- Immune-Mediated Necrotizing Myopathy
- (2018) Iago Pinal-Fernandez et al. Current Rheumatology Reports
- 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups
- (2017) Ingrid E. Lundberg et al. Arthritis & Rheumatology
- Inflammatory Muscle Diseases
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Pandemic unadjuvanted influenza A (H1N1) vaccine in dermatomyositis and polymyositis: Immunogenicity independent of therapy and no harmful effect in disease
- (2012) Samuel Katsuyuki Shinjo et al. VACCINE
- Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases
- (2011) C. G. S. Saad et al. ANNALS OF THE RHEUMATIC DISEASES
- Infectious Complications in Polymyositis and Dermatomyositis: A Series of 279 Patients
- (2010) Isabelle Marie et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Distribution and severity of weakness among patients with polymyositis, dermatomyositis and juvenile dermatomyositis
- (2008) M. O. Harris-Love et al. RHEUMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started